Targeting the NLRP3 inflammasome signalling for the management of atrial fibrillation.

MLA

Niskala, Alisha, et al. “Targeting the NLRP3 Inflammasome Signalling for the Management of Atrial Fibrillation.” British Journal of Pharmacology, vol. 181, no. 24, Dec. 2024, pp. 4939–57. EBSCOhost, https://doi.org/10.1111/bph.16470.

APA

Niskala, A., Heijman, J., Dobrev, D., Jespersen, T., & Saljic, A. (2024). Targeting the NLRP3 inflammasome signalling for the management of atrial fibrillation. British Journal of Pharmacology, 181(24), 4939–4957. https://doi.org/10.1111/bph.16470

Chicago

Niskala, Alisha, Jordi Heijman, Dobromir Dobrev, Thomas Jespersen, and Arnela Saljic. 2024. “Targeting the NLRP3 Inflammasome Signalling for the Management of Atrial Fibrillation.” British Journal of Pharmacology 181 (24): 4939–57. doi:10.1111/bph.16470.